Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Scientific Reports|January 5, 2016
Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrumSynne Jenum, S Dhanasekaran, Rakesh Lodha, et al.
Vaccine|March 23, 2005
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6Jan A M Langermans, T Mark Doherty, Richard A W Vervenne, et al.
European Geriatric Medicine|June 12, 2018
Vaccination programs for older adults in an era of demographic changeT Mark Doherty, Mark P Connolly, Giuseppe Del Giudice, et al.
BMC Infectious Diseases|January 21, 2012
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden settingNovel N Chegou, Gillian F Black, Andre G Loxton, et al.
The Oncologist|July 3, 2021
Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung CancerMichael C Tjong, Mark Doherty, Hendrick Tan, et al.
The Journal of Infectious Diseases|November 27, 2009
High heritability of antimycobacterial immunity in an area of hyperendemicity for tuberculosis diseaseAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Chest|December 31, 2009
Tuberculin skin test and in vitro assays provide complementary measures of antimycobacterial immunity in children and adolescentsCaroline J Gallant, Aurelie Cobat, Leah Simkin, et al.
Vaccine|January 25, 2011
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infectionJaap T van Dissel, Darius Soonawala, Simone A Joosten, et al.
Future Oncology (London, England)|May 7, 2020
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)Mairéad Geraldine McNamara, Lipika Goyal, Mark Doherty, et al.
Journal of Thoracic Disease|March 13, 2023
Dyspnea in patients with stage IV non-small cell lung cancer: a population-based analysis of disease burden and patterns of careMichael Yan, Michael Tjong, Wing C Chan, et al.
Pageof 21